Study Highlights Long Island's High Burden of Sickle Cell Disease and Its Implications
A recent study conducted by researchers at NYU School of Global Public Health has revealed that Long Island, New York, bears a significant burden of sickle cell disease (SCD), a common inherited blood disorder. The study analyzed data from 42,200 SCD hospitalizations in New York State between 2009 and 2022, focusing on hospital stay lengths, total charges, illness severity, and mortality risk. While New York City had the highest number of hospitalizations, Long Island had the highest percentage of hospitalizations with a major risk of death, indicating a high disease burden. SCD is caused by a genetic mutation affecting hemoglobin production, leading to crescent-shaped blood cells that impair oxygen transport, resulting in severe health complications. The study also noted that Long Island had the highest total charges for hospital stays, reflecting the complexity of cases managed in the region. 
